Rothschild & CO Asset Management Us Inc. Medpace Holdings, Inc. Transaction History

Rothschild & CO Asset Management Us Inc.

$6.56 Billion
Q4 2022

A detailed history of Rothschild & CO Asset Management Us Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Rothschild & CO Asset Management Us Inc. holds 27,353 shares of MEDP stock, worth $11 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

27,353

Previous 31,573 13.37%

Holding current value

$11 Million

Previous $4.96 Million 17.09%

% of portfolio

0.09%

Previous 0.08%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$153.06 - $226.57 $645,913 - $956,125	-4,220 Reduced 13.37%	27,353 $5.81 Million
Q3 2022 Nov 07, 2022	BUY	$145.13 - $182.49 $89,109 - $112,048	614 Added 1.98%	31,573 $4.96 Million
Q2 2022 Aug 09, 2022	SELL	$130.2 - $168.03 $132,413 - $170,886	-1,017 Reduced 3.18%	30,959 $4.63 Million
Q1 2022 May 13, 2022	SELL	$138.87 - $214.31 $1.63 Million - $2.51 Million	-11,725 Reduced 26.83%	31,976 $5.23 Million
Q4 2021 Feb 11, 2022	SELL	$182.74 - $227.9 $529,946 - $660,910	-2,900 Reduced 6.22%	43,701 $9.51 Million

Q3 2021 Nov 09, 2021	SELL	$170.18 - $198.21 $1.24 Million - $1.44 Million	-7,290 Reduced 13.53%	46,601 $8.82 Million
Q2 2021 Aug 16, 2021	SELL	$158.62 - $194.3 $296,302 - $362,952	-1,868 Reduced 3.35%	53,891 $9.52 Million
Q1 2021 May 14, 2021	SELL	$132.02 - $168.26 $946,847 - $1.21 Million	-7,172 Reduced 11.4%	55,759 $9.15 Million
Q4 2020 Feb 08, 2021	BUY	$109.38 - $149.19 $6.88 Million - $9.39 Million	62,931 New	62,931 $8.76 Million

Others Institutions Holding MEDP

# of Institutions

622

Shares Held

25.1M

Call Options Held

154K

Put Options Held

117K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $12.5B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild & CO Asset Management Us Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rothschild & CO Asset Management Us Inc. with notifications on news.

Account

Rothschild & CO Asset Management Us Inc. Medpace Holdings, Inc. Transaction History